<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01026961</url>
  </required_header>
  <id_info>
    <org_study_id>381-A-101</org_study_id>
    <nct_id>NCT01026961</nct_id>
  </id_info>
  <brief_title>Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers</brief_title>
  <official_title>A Randomized, Crossover, Double-Blind Study To Evaluate The Safety Of An Association Of Phenylephrine Hydrochloride 10mg + Acetaminophen 500mg + Dimethindene Maleate 1 Mg Compared To Phenylephrine Hydrochloride 10mg In Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety of phenylephrine hydrochloride 10 mg + acetaminophen 500
      mg + dimethindene maleate 1 mg compared to phenylephrine hydrocloride 10 mg alone in healthy
      volunteers.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <why_stopped>
    Study is no longer required by Brazil health authority.
  </why_stopped>
  <start_date>September 2010</start_date>
  <primary_completion_date type="Anticipated">November 2010</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To compare the effect of phenylephrine hydrochloride 10mg + acetaminophen 500mg + dimethindene maleate 1mg and phenylephrine hydrochloride 10mg alone on vital signs</measure>
    <time_frame>15 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Electrocardiographic (ECG) monitoring and evaluation of heart rhythm following dosing</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To report and evaluate adverse events</measure>
    <time_frame>15 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Heart Rate</condition>
  <condition>Blood Pressure</condition>
  <condition>Arrhythmias</condition>
  <arm_group>
    <arm_group_label>Phenylephrine HCL/Acetaminophen/Dimethindene Maleate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Phenylephrine HCL/Acetaminophen/Dimethindene Maleate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenylephrine hydrochloride</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phenylephrine hydrochloride 10mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine HCL</intervention_name>
    <description>Phenylephrine HCL 10mg</description>
    <arm_group_label>Phenylephrine hydrochloride</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine HCL/Acetaminophen/Dimethindene Maleate</intervention_name>
    <description>Phenylephrine HCL 10mg/Acetaminophen 500mg/Dimethindene Maleate 1mg</description>
    <arm_group_label>Phenylephrine HCL/Acetaminophen/Dimethindene Maleate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers between 18 and 50 years;

          -  Clinical examination without abnormal findings

          -  Ability to understand the nature and purpose of the study, including the risks and
             adverse effects

        Exclusion Criteria:

          -  Any cardiovascular disease, coronary artery disease, circulation problems or history
             of stroke, peripheral vascular disease or arrhythmia

          -  History of serious adverse reactions or hypersensitivity any drug

          -  Hypersensitivity to the drug study drugs or chemically related compounds
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Novartis Biociências S.A</last_name>
    <role>Study Director</role>
    <affiliation>Novartis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Scentryphar Pesquisa Clinica Ltda.</name>
      <address>
        <city>Campinas</city>
        <state>São Paulo</state>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <link>
    <url>http://prsinfo.clinicaltrials.gov</url>
  </link>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 4, 2009</study_first_submitted>
  <study_first_submitted_qc>December 4, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2009</study_first_posted>
  <last_update_submitted>March 2, 2016</last_update_submitted>
  <last_update_submitted_qc>March 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 3, 2016</last_update_posted>
  <responsible_party>
    <name_title>External Affairs</name_title>
    <organization>Novartis Biociências S.A</organization>
  </responsible_party>
  <keyword>Safety</keyword>
  <keyword>heart rate</keyword>
  <keyword>systolic and diastolic blood pressure</keyword>
  <keyword>arrhythmias</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Maleic acid</mesh_term>
    <mesh_term>Dimethindene</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

